CN102961720B - Medicament for treating epidural post anesthesia lumbago and backache - Google Patents

Medicament for treating epidural post anesthesia lumbago and backache Download PDF

Info

Publication number
CN102961720B
CN102961720B CN2012105348125A CN201210534812A CN102961720B CN 102961720 B CN102961720 B CN 102961720B CN 2012105348125 A CN2012105348125 A CN 2012105348125A CN 201210534812 A CN201210534812 A CN 201210534812A CN 102961720 B CN102961720 B CN 102961720B
Authority
CN
China
Prior art keywords
parts
herba
medicament
backache
lumbago
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2012105348125A
Other languages
Chinese (zh)
Other versions
CN102961720A (en
Inventor
王昆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012105348125A priority Critical patent/CN102961720B/en
Publication of CN102961720A publication Critical patent/CN102961720A/en
Application granted granted Critical
Publication of CN102961720B publication Critical patent/CN102961720B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicament for treating epidural post anesthesia lumbago and backache. The medicament comprises the following materials in parts by weight: 10-20 parts of herba dracocephali integrifolii, 10-25 parts of erycibe obtusifolia, 1-15 parts of soldago decurrens lour, 1-10 parts of kamuning, 1-15 parts of saposhnicovia divaricata, 1-10 parts of trichomanes japonicum thunb., 1-10 parts of dried ginger, 1-15 parts of folium isatidis, 1-10 parts of medulla helwingiae, 10-20 parts of cremastra appendiculata, 10-30 parts of rhizoma arisasmatis, 1-20 parts of semen plantaginis, 1-10 parts of kansui root, 10-20 parts of salvia chinensis and 1-10 parts of bighead atractylodes rhizome. The medicament for treating epidural post anesthesia lumbago and backache has the characteristics of being low in cost, easy to prepare, less in toxic and side effects, and obvious in curative effect.

Description

A kind of medicament for the treatment of lumbago and backache after epidural anesthesia
Technical field
The present invention relates to the Anesthesia Department field, specifically, relate to a kind of medicament for the treatment of lumbago and backache after epidural anesthesia.
Background technology
Lumbago and backache is common complication after epidural anesthesia, and incidence rate is at 2%-31%.Its possible reason be when puncture local damage cause the soft tissue aseptic inflammatory reaction such as ligament, periosteum, lesion ports repeatedly while repeatedly puncturing, the anesthesia posterior spinal loses the muscle supporting role and keeps for a long time same posture clinostatism etc.Therefore, in the urgent need to finding a kind of medicament for the treatment of lumbago and backache after epidural anesthesia.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of lumbago and backache after epidural anesthesia.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of lumbago and backache after epidural anesthesia, it is to be made by the material of following weight proportioning: Herba Dracocephali Integrifolii 10-20 part, Caulis Erycibes 10-25 part, Herba Solidaginis 1-15 part, Folium Et Cacumen Murrayae 1-10 part, Radix Saposhnikoviae 1-15 part, Herba Pteridis creticae 1-10 part, Rhizoma Zingiberis 1-10 part, Folium Isatidis 1-15 part, Medulla Stachyuri (Medulla Helwingiae) 1-10 part, Pseudobulbus Cremastrae Seu Pleiones 10-20 part, Rhizoma Arisaematis 10-30 part, Semen Plantaginis 1-20 part, Radix Kansui 1-10 part, Herba Salviae Chinensis 10-20 part and Rhizoma Atractylodis Macrocephalae 1-10 part.
Preferably, after treatment epidural anesthesia of the present invention, the medicament of lumbago and backache is to be made by the material of following weight proportioning: 5 parts of 15 parts of Herba Dracocephali Integrifoliis, 20 parts of Caulis Erycibess, 10 parts of Herba Solidaginiss, 5 parts of Folium Et Cacumen Murrayae, 10 parts of Radix Saposhnikoviaes, 5 parts of Herba Pteridis creticae, 5 parts of Rhizoma Zingiberiss, 10 parts of Folium Isatidiss, 5 parts of Medulla Stachyuri (Medulla Helwingiae)s, 15 parts of Pseudobulbus Cremastrae Seu Pleioness, 20 parts of Rhizoma Arisaematiss, 10 parts of Semen Plantaginiss, 5 parts of Radix Kansuis, 15 parts of Herba Salviae Chinensiss and the Rhizoma Atractylodis Macrocephalaes.
Preferably, medicament of the present invention is tablet, buccal tablet, instant or decoction.
After treatment epidural anesthesia of the present invention, the medicament of lumbago and backache has the advantages that cost is low, preparation is easy, toxic and side effects is little, curative effect is showing.
The specific embodiment
Embodiment 1: the preparation of decoction of the present invention
Claim Herba Dracocephali Integrifolii 15 grams, Caulis Erycibes 20 grams, Herba Solidaginis 10 grams, Folium Et Cacumen Murrayae 5 grams, Radix Saposhnikoviae 10 grams, Herba Pteridis creticae 5 grams, Rhizoma Zingiberis 5 grams, Folium Isatidis 10 grams, Medulla Stachyuri (Medulla Helwingiae) 5 grams, Pseudobulbus Cremastrae Seu Pleiones 15 grams, Rhizoma Arisaematis 20 grams, Semen Plantaginis 10 grams, Radix Kansui 5 grams, Herba Salviae Chinensis 15 grams and the Rhizoma Atractylodis Macrocephalae 5 grams, add 1000 milliliters, water, be placed in the flask of sealing, under the water-bath of 90 ℃, heating is 3 hours, filter, collect filtrate and get final product.
Experimental example
60 routine patients, male 23 examples wherein, female's 37 examples, 23-55 year, average (35.4 ± 6.3) year, the course of disease 2 months-8 years.The epidural puncture gap is from T 8-9To L 3-4, wherein 4 examples were crossed epidural anesthesia 2 times at same gap acceptance more than 30min 35 routine anesthesia procedure times.Pain by the puncture gap centered by, diameter 5-9cm, persistence is ached, dull pain is main.Be divided into treatment group and matched group, every group of 30 examples.The customary coherence check of all cases, get rid of tumor, anemia of pregnant woman, dysfunction of blood coagulation, serious cardiopathic patient.The difference (P>0.05) of processing that there are no significant is learned in two groups of physical data, clinical manifestations by statistics, has comparability.
The decoction of oral embodiment 1 preparation for the treatment of group, every twice-daily,, treat 4 weeks by each 50 milliliters.Matched group adopts outside nursing to be treated.Use the BYL-05C infrared polarization light of type (super laser) therapeutic instrument (Beijing treasure dragon is health scientific & trading Co., Ltd. only) treatment, therapentic part, centered by the lower back pressure pain point, adopts C type treatment head, output 2800mW, spot diameter 10cm irradiates 15min at every turn, 1 time weekly, totally 4 times.
Criterion of therapeutical effect
Adopt visual analogue scales (visual analoguescale VAS) evaluation patient lumbago and backache.Evaluation criteria: 0 is divided into healing, fully painless after treatment; 1-3 is divided into alleviation, after treatment, alleviates obviously but still sense pain; Be greater than 3 and be divided into invalidly, alleviate but not obvious with comparing to some extent before treatment.
Therapeutic outcome
Two groups of patients are at age, sex, body weight, operation kind, operating time, painful area side and the difference not statistically significant is treated front two groups of patient VAS scoring not statistically significant.After treating 4 weeks, the scoring for the treatment of group VAS obviously reduces (P<0.01), and the cure rate for the treatment of group is apparently higher than the cure rate of matched group.The results are shown in Table 1.
Visual analogue scale before and after two groups of treatments of lumbago and backache after table 1 anesthesia
Figure BSA00000822061000031
Annotate: with matched group, compare, 1. P<0.01
Safety analysis
Do not occur serious adverse reaction in observation, after treatment finishes, treatment group patient's blood, urine, stool routine and hepatic and renal function inspection are showed no extremely.

Claims (2)

1. a medicament for the treatment of lumbago and backache after epidural anesthesia, is characterized in that it is to be made by the material of following weight proportioning: Herba Dracocephali Integrifolii 10-20 part, Caulis Erycibes 10-25 part, Herba Solidaginis 1-15 part, Folium Et Cacumen Murrayae 1-10 part, Radix Saposhnikoviae 1-15 part, Herba Pteridis creticae 1-10 part, Rhizoma Zingiberis 1-10 part, Folium Isatidis 1-15 part, Medulla Stachyuri (Medulla Helwingiae) 1-10 part, Pseudobulbus Cremastrae Seu Pleiones 10-20 part, Rhizoma Arisaematis 10-30 part, Semen Plantaginis 1-20 part, Radix Kansui 1-10 part, Herba Salviae Chinensis 10-20 part and Rhizoma Atractylodis Macrocephalae 1-10 part.
2. the medicament of lumbago and backache after treatment epidural anesthesia according to claim 1 is characterized in that it is to be made by the material of following weight proportioning: 5 parts of 15 parts of Herba Dracocephali Integrifoliis, 20 parts of Caulis Erycibess, 10 parts of Herba Solidaginiss, 5 parts of Folium Et Cacumen Murrayae, 10 parts of Radix Saposhnikoviaes, 5 parts of Herba Pteridis creticae, 5 parts of Rhizoma Zingiberiss, 10 parts of Folium Isatidiss, 5 parts of Medulla Stachyuri (Medulla Helwingiae)s, 15 parts of Pseudobulbus Cremastrae Seu Pleioness, 20 parts of Rhizoma Arisaematiss, 10 parts of Semen Plantaginiss, 5 parts of Radix Kansuis, 15 parts of Herba Salviae Chinensiss and the Rhizoma Atractylodis Macrocephalaes.
CN2012105348125A 2012-12-06 2012-12-06 Medicament for treating epidural post anesthesia lumbago and backache Expired - Fee Related CN102961720B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012105348125A CN102961720B (en) 2012-12-06 2012-12-06 Medicament for treating epidural post anesthesia lumbago and backache

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012105348125A CN102961720B (en) 2012-12-06 2012-12-06 Medicament for treating epidural post anesthesia lumbago and backache

Publications (2)

Publication Number Publication Date
CN102961720A CN102961720A (en) 2013-03-13
CN102961720B true CN102961720B (en) 2013-12-04

Family

ID=47792339

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012105348125A Expired - Fee Related CN102961720B (en) 2012-12-06 2012-12-06 Medicament for treating epidural post anesthesia lumbago and backache

Country Status (1)

Country Link
CN (1) CN102961720B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101954057A (en) * 2010-09-04 2011-01-26 荣成市新技术应用研究所 Traditional Chinese medicinal composition for treating pain in waist and lower extremities
CN102008666B (en) * 2010-11-30 2012-03-21 赵柏英 Drug for treating lumbocrural pain

Also Published As

Publication number Publication date
CN102961720A (en) 2013-03-13

Similar Documents

Publication Publication Date Title
CN104758659A (en) Traditional Chinese medicine paste for treating muscle and bone diseases
CN101491653B (en) Traditional Chinese medicine composite for treating rosacea and use method thereof
CN103027978A (en) Medicine composition for treating traumatic injury and preparation method of medicine composition
CN105639005A (en) Russula sanguinaria health tea and preparation method thereof
CN102743703B (en) Medicament for treating cervical spondylosis and preparation method thereof
CN102961720B (en) Medicament for treating epidural post anesthesia lumbago and backache
CN104383242A (en) Medicament composition for treating ovarian cyst and preparation method thereof
CN103463340B (en) One treats migrainous Chinese medicine preparation
CN104258295A (en) Traditional Chinese medicine decoction for treating lymphoma
CN104606455B (en) A kind of medicament for the treatment of lumbar muscle strain
CN103800664A (en) Traditional Chinese medicine composition for treating menopausal syndrome
CN104352669B (en) A kind of application of Chinese medicine in weak sperm disease is treated
CN104606402B (en) A kind of Chinese medicine composition, preparation and preparation method, purposes
CN103191342B (en) Method for preparing diaphyseal aclasis nursing substance
CN102908588B (en) Medicament for treating rigid rhachitis
CN102526385A (en) Medicament for treating climacteric syndrome
CN102727710B (en) Medicine for treating aplastic anemia
CN104740579A (en) Premenstrual calming tablet and preparation process thereof
CN104815132A (en) External lotion for treating low back and leg pain and preparation method
CN105327288A (en) Drug for treating breast hyperplasia
CN105106713A (en) Traditional Chinese medicine preparation for treating chronic aplastic anemia
CN104606553B (en) A kind of pharmaceutical composition for the treatment of hemopenia fever in puerperal
CN105535817A (en) A traditional Chinese medicine composition containing argy wormwood leaves and used for treating cervical spondylosis and a preparing method thereof
CN105326972A (en) External medicine composition for treating traumata and skin and external diseases
CN104547915A (en) Traditional Chinese medicine composition for treating traumatic injury and medicinal liquor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131204

Termination date: 20141206

EXPY Termination of patent right or utility model